Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Micron Technology Inc ha un prezzo obiettivo di consenso di $210.29 basato sulle valutazioni di 29 analisti. Il massimo è $325, pubblicato da Morgan Stanley il novembre 13, 2025. Il minimo è $84, pubblicato da China Renaissance il marzo 26, 2025. Le 3 valutazioni di analisti più recenti sono state pubblicate da UBS, Rosenblatt e Morgan Stanley il novembre 20, 2025, novembre 17, 2025 e novembre 13, 2025. Con un prezzo obiettivo medio di $300 tra UBS, Rosenblatt e Morgan Stanley, c’è una variazione implicita del 43.95% upside per Micron Technology Inc a partire da queste ultime valutazioni degli analisti.
1calcolato in base alle valutazioni degli analisti
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/20/2025 | 31.96% | UBS | $245 → $275 | Maintains | Buy | |||
11/17/2025 | 43.95% | Rosenblatt | $250 → $300 | Maintains | Buy | |||
11/13/2025 | 55.95% | Morgan Stanley | $220 → $325 | Maintains | Overweight | |||
11/07/2025 | 43.95% | Wells Fargo | $220 → $300 | Maintains | Overweight | |||
10/28/2025 | 27.16% | Mizuho | $240 → $265 | Maintains | Outperform | |||
10/27/2025 | 31.96% | Citigroup | $240 → $275 | Maintains | Buy | |||
10/20/2025 | 15.16% | Barclays | $195 → $240 | Maintains | Overweight | |||
10/17/2025 | 15.16% | Mizuho | $195 → $240 | Maintains | Outperform | |||
10/16/2025 | 17.56% | UBS | $225 → $245 | Maintains | Buy | |||
10/16/2025 | 15.16% | Citigroup | $200 → $240 | Maintains | Buy | |||
10/14/2025 | — | New Street Research | — | Downgrade | Buy → Neutral | |||
10/09/2025 | -13.63% | Goldman Sachs | $145 → $180 | Maintains | Neutral | |||
10/08/2025 | 7.97% | UBS | $195 → $225 | Maintains | Buy | |||
10/07/2025 | 19.48% | Itau BBA | — | → $249 | Initiates | → Outperform | ||
10/06/2025 | 5.57% | Morgan Stanley | $160 → $220 | Upgrade | Equal-Weight → Overweight | |||
09/24/2025 | -4.03% | Deutsche Bank | $175 → $200 | Maintains | Buy | |||
09/24/2025 | -30.42% | Goldman Sachs | $130 → $145 | Maintains | Neutral | |||
09/24/2025 | -6.43% | Stifel | $173 → $195 | Maintains | Buy | |||
09/24/2025 | -8.83% | Raymond James | $150 → $190 | Reiterates | Outperform → Outperform | |||
09/24/2025 | -4.03% | Piper Sandler | $165 → $200 | Reiterates | Overweight → Overweight | |||
09/24/2025 | -4.03% | TD Cowen | $180 → $200 | Maintains | Buy | |||
09/24/2025 | -6.43% | UBS | $185 → $195 | Maintains | Buy | |||
09/24/2025 | -4.03% | Citigroup | $175 → $200 | Maintains | Buy | |||
09/24/2025 | -6.43% | Mizuho | $182 → $195 | Maintains | Outperform | |||
09/24/2025 | 5.57% | Wedbush | $200 → $220 | Maintains | Outperform | |||
09/24/2025 | 5.57% | Wells Fargo | $170 → $220 | Maintains | Overweight | |||
09/24/2025 | -6.43% | Barclays | $175 → $195 | Maintains | Overweight | |||
09/24/2025 | 5.57% | JP Morgan | $185 → $220 | Maintains | Overweight | |||
09/24/2025 | -13.63% | B of A Securities | $140 → $180 | Maintains | Neutral | |||
09/24/2025 | 3.17% | Keybanc | $160 → $215 | Maintains | Overweight | |||
09/24/2025 | 19.96% | Rosenblatt | $200 → $250 | Maintains | Buy | |||
09/24/2025 | -4.03% | Needham | $150 → $200 | Maintains | Buy | |||
09/22/2025 | -23.22% | Morgan Stanley | $135 → $160 | Maintains | Equal-Weight | |||
09/22/2025 | -16.99% | Stifel | $145 → $173 | Maintains | Buy | |||
09/19/2025 | -16.03% | Barclays | $140 → $175 | Maintains | Overweight | |||
09/18/2025 | -4.03% | Wedbush | $165 → $200 | Maintains | Outperform | |||
09/18/2025 | -4.03% | Rosenblatt | $200 → $200 | Maintains | Buy | |||
09/17/2025 | -4.03% | Susquehanna | $160 → $200 | Maintains | Positive | |||
09/17/2025 | -13.63% | Wolfe Research | $160 → $180 | Maintains | Outperform | |||
09/16/2025 | -12.67% | Mizuho | $155 → $182 | Maintains | Outperform | |||
09/15/2025 | -16.03% | Deutsche Bank | $150 → $175 | Maintains | Buy | |||
09/15/2025 | -11.23% | UBS | $155 → $185 | Maintains | Buy | |||
09/15/2025 | -11.23% | Cantor Fitzgerald | $155 → $185 | Maintains | Overweight | |||
09/11/2025 | -16.03% | Citigroup | $150 → $175 | Maintains | Buy | |||
08/27/2025 | -25.62% | CLSA | → $155 | Initiates | → Outperform | |||
08/12/2025 | -11.23% | JP Morgan | $165 → $185 | Maintains | Overweight | |||
08/11/2025 | -4.03% | Rosenblatt | $200 → $200 | Maintains | Buy | |||
08/11/2025 | -28.02% | Needham | $150 → $150 | Reiterates | Buy → Buy | |||
07/10/2025 | -28.02% | Deutsche Bank | → $150 | Initiates | → Buy | |||
07/10/2025 | -37.62% | Goldman Sachs | → $130 | Initiates | → Neutral | |||
06/27/2025 | -4.03% | Baird | $163 → $200 | Maintains | Outperform | |||
06/26/2025 | -23.22% | Susquehanna | $150 → $160 | Maintains | Positive | |||
06/26/2025 | -30.42% | Stifel | $130 → $145 | Maintains | Buy | |||
06/26/2025 | -20.83% | Piper Sandler | $120 → $165 | Reiterates | Overweight → Overweight | |||
06/26/2025 | -28.02% | Raymond James | $120 → $150 | Maintains | Outperform | |||
06/26/2025 | -23.22% | Keybanc | $135 → $160 | Maintains | Overweight | |||
06/26/2025 | -18.43% | Wells Fargo | $150 → $170 | Maintains | Overweight | |||
06/26/2025 | -25.62% | UBS | $120 → $155 | Maintains | Buy | |||
06/26/2025 | -35.22% | Morgan Stanley | $98 → $135 | Maintains | Equal-Weight | |||
06/26/2025 | -28.02% | Citigroup | $130 → $150 | Maintains | Buy | |||
06/26/2025 | -20.83% | Wedbush | $150 → $165 | Maintains | Outperform | |||
06/26/2025 | -25.62% | Cantor Fitzgerald | $145 → $155 | Maintains | Overweight | |||
06/26/2025 | -32.82% | Barclays | $95 → $140 | Maintains | Overweight | |||
06/26/2025 | -32.82% | B of A Securities | $84 → $140 | Maintains | Neutral | |||
06/26/2025 | -20.83% | JP Morgan | $135 → $165 | Maintains | Overweight | |||
06/26/2025 | -28.02% | Needham | $120 → $150 | Maintains | Buy | |||
06/26/2025 | -4.03% | Rosenblatt | $172 → $200 | Maintains | Buy | |||
06/23/2025 | -17.47% | Rosenblatt | $172 → $172 | Maintains | Buy | |||
06/20/2025 | -28.02% | Wedbush | $130 → $150 | Maintains | Outperform | |||
06/20/2025 | -28.02% | Wells Fargo | $130 → $150 | Maintains | Overweight | |||
06/09/2025 | -37.62% | Citigroup | $110 → $130 | Maintains | Buy | |||
06/05/2025 | -37.62% | Mizuho | $124 → $130 | Maintains | Outperform | |||
06/05/2025 | -42.42% | UBS | $92 → $120 | Maintains | Buy | |||
05/07/2025 | -52.98% | Morgan Stanley | $112 → $98 | Maintains | Equal-Weight | |||
04/28/2025 | -55.85% | UBS | $130 → $92 | Maintains | Buy | |||
04/22/2025 | -54.41% | Barclays | $115 → $95 | Maintains | Overweight | |||
04/16/2025 | -59.69% | B of A Securities | $110 → $84 | Maintains | Neutral | |||
04/11/2025 | -47.22% | Citigroup | $120 → $110 | Maintains | Buy | |||
03/26/2025 | -59.69% | China Renaissance | → $84 | Downgrade | Buy → Hold | |||
03/21/2025 | -40.5% | Mizuho | $115 → $124 | Maintains | Outperform | |||
03/21/2025 | -42.42% | Citigroup | $150 → $120 | Maintains | Buy | |||
03/21/2025 | -44.82% | Barclays | $110 → $115 | Maintains | Overweight | |||
03/21/2025 | -46.26% | Morgan Stanley | $91 → $112 | Maintains | Equal-Weight | |||
03/21/2025 | -35.22% | JP Morgan | $145 → $135 | Maintains | Overweight | |||
03/21/2025 | -37.62% | Wedbush | $125 → $130 | Maintains | Outperform | |||
03/21/2025 | -37.62% | Cantor Fitzgerald | $130 → $130 | Reiterates | Overweight → Overweight | |||
03/21/2025 | -21.79% | Baird | $130 → $163 | Maintains | Outperform | |||
03/21/2025 | -4.03% | Rosenblatt | $250 → $200 | Maintains | Buy | |||
03/19/2025 | -44.82% | Mizuho | $115 → $115 | Maintains | Outperform | |||
03/17/2025 | -37.62% | UBS | $125 → $130 | Maintains | Buy | |||
03/17/2025 | -40.02% | Wedbush | $125 → $125 | Reiterates | Outperform → Outperform | |||
03/13/2025 | -37.62% | Wells Fargo | $140 → $130 | Maintains | Overweight | |||
01/28/2025 | -56.33% | Morgan Stanley | $98 → $91 | Maintains | Equal-Weight | |||
12/20/2024 | -47.22% | Barclays | $145 → $110 | Maintains | Overweight | |||
12/19/2024 | -42.42% | Raymond James | $140 → $120 | Maintains | Outperform | |||
12/19/2024 | -42.42% | Piper Sandler | $150 → $120 | Maintains | Overweight | |||
12/19/2024 | -52.98% | Morgan Stanley | $114 → $98 | Maintains | Equal-Weight | |||
12/19/2024 | -40.02% | TD Cowen | $135 → $125 | Maintains | Buy | |||
12/19/2024 | -30.42% | JP Morgan | $180 → $145 | Maintains | Overweight | |||
12/19/2024 | -37.62% | Cantor Fitzgerald | $150 → $130 | Maintains | Overweight |
L'ultimo obiettivo di prezzo per Micron Technology (NASDAQ:MU) è stato riportato da {{analyst} in data {{date}}. La società di analisi ha fissato un obiettivo di prezzo per $275.00 prevedendo che MU raggiunga rise entro 12 mesi (un possibile 31.96% upside).
L'ultima valutazione degli analisti per Micron Technology (NASDAQ:MU) è stato fornita da UBS e Micron Technology mantenuto il suo rating buy.
L'ultima revisione al rialzo di Micron Technology Inc è avvenuta il ottobre 6, 2025, quando Morgan Stanley ha alzato il suo obiettivo di prezzo a $220. In precedenza Morgan Stanley aveva an equal-weight per Micron Technology Inc.
L'ultima revisione al ribasso di Micron Technology Inc si è verificata il ottobre 14, 2025, quando New Street Research ha modificato il suo obiettivo di prezzo da N/A a N/A per Micron Technology Inc.
Gli analisti giungono alle valutazioni dei titoli dopo aver fatto ricerche approfondite, che comprendono l'esame dei bilanci pubblici, i colloqui con i dirigenti e i clienti di Micron Technology e l'ascolto delle comunicazioni degli utili. La maggior parte degli analisti svolge questa attività ogni tre mesi, quindi dovresti ricevere 4 valutazioni all'anno per azienda e per società. L'ultima valutazione di Micron Technology è stata depositata il novembre 20, 2025, quindi dovresti aspettarti che la prossima valutazione sia disponibile intorno a novembre 20, 2026.
Sebbene le valutazioni siano soggettive e possano cambiare, l'ultima valutazione di Micron Technology (MU) è stata una mantenuto con un obiettivo di prezzo di $245.00 a $275.00. Il prezzo attuale a cui Micron Technology (MU) è scambiato è $208.40, che è out of del range previsto dall'analista.
Sfoglia valutazioni degli analisti e obiettivi di prezzo su tutte le azioni.